DK0448930T3 - Stabile præparater til parenteral administration og fremgangsmåde til fremstilling deraf - Google Patents

Stabile præparater til parenteral administration og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0448930T3
DK0448930T3 DK91100650.0T DK91100650T DK0448930T3 DK 0448930 T3 DK0448930 T3 DK 0448930T3 DK 91100650 T DK91100650 T DK 91100650T DK 0448930 T3 DK0448930 T3 DK 0448930T3
Authority
DK
Denmark
Prior art keywords
preparation
methods
parenteral administration
stable preparations
preparations
Prior art date
Application number
DK91100650.0T
Other languages
English (en)
Inventor
William Steber
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0448930T3 publication Critical patent/DK0448930T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK91100650.0T 1990-03-30 1991-01-21 Stabile præparater til parenteral administration og fremgangsmåde til fremstilling deraf DK0448930T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/502,382 US5213810A (en) 1990-03-30 1990-03-30 Stable compositions for parenteral administration and method of making same

Publications (1)

Publication Number Publication Date
DK0448930T3 true DK0448930T3 (da) 1994-06-20

Family

ID=23997559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91100650.0T DK0448930T3 (da) 1990-03-30 1991-01-21 Stabile præparater til parenteral administration og fremgangsmåde til fremstilling deraf

Country Status (29)

Country Link
US (1) US5213810A (da)
EP (1) EP0448930B1 (da)
JP (1) JP2966564B2 (da)
KR (1) KR0159778B1 (da)
CN (1) CN1063941C (da)
AR (1) AR248085A1 (da)
AT (1) ATE106240T1 (da)
AU (1) AU641994B2 (da)
BG (1) BG60850B1 (da)
CA (1) CA2039491C (da)
CZ (1) CZ283053B6 (da)
DE (1) DE69102176T2 (da)
DK (1) DK0448930T3 (da)
ES (1) ES2054380T3 (da)
FI (1) FI101676B (da)
HK (1) HK1000004A1 (da)
HU (1) HU219584B (da)
IE (1) IE65970B1 (da)
IL (1) IL97145A (da)
MX (1) MX172602B (da)
NO (1) NO300717B1 (da)
NZ (1) NZ237509A (da)
PL (1) PL167692B1 (da)
PT (1) PT97160B (da)
RO (1) RO106191B1 (da)
RU (1) RU2011377C1 (da)
SK (1) SK279461B6 (da)
YU (1) YU47650B (da)
ZA (1) ZA912398B (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69208765T2 (de) * 1991-07-23 1996-09-26 American Cyanamid Co Stabile Zusammensetzungen für parenterale Verabrechung und ihre Verwendung
WO1994017106A1 (en) * 1993-01-19 1994-08-04 Pharmacia P-L Biochemicals, Inc. Storage and delivery of purified protein reagents with carrier wax
US5599660A (en) * 1993-01-19 1997-02-04 Pharmacia Biotech Inc. Method and preparation for sequential delivery of wax-embedded, inactivated biological and chemical reagents
US6083430A (en) * 1994-10-28 2000-07-04 Fuisz Technologies Ltd. Method of preparing a dosage unit by direct tableting and product therefrom
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
PT750854E (pt) * 1995-06-29 2002-04-29 Nestle Sa Processo para a encapsulacao de um material de nucleo com um polimero por tratamento a alta pressao
US6692767B2 (en) 1997-09-19 2004-02-17 Shire Laboratories Inc. Solid solution beadlet
AU2002300572B2 (en) * 1997-09-19 2004-11-25 Shire Laboratories, Inc. Solid Solution Beadlet
US6117452A (en) * 1998-08-12 2000-09-12 Fuisz Technologies Ltd. Fatty ester combinations
WO2000067728A2 (de) * 1999-05-07 2000-11-16 Pharmasol Gmbh Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung
US8663692B1 (en) * 1999-05-07 2014-03-04 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
CZ20014405A3 (cs) * 1999-06-07 2002-04-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Léková forma
IES990700A2 (en) * 1999-08-18 2001-08-22 Kinerton Ltd Process to make a sustained release formulation
NZ526127A (en) * 1999-08-18 2005-02-25 Sod Conseils Rech Applic Use of a somatostatin analog in the manufacture of a medicament
AU2001257359A1 (en) 2000-04-27 2001-11-07 Verion Inc. Zero order release and temperature-controlled microcapsules and process for the preparation thereof
DE60125176T3 (de) * 2000-06-26 2015-07-23 Dsm Ip Assets B.V. Verbesserte Verfahren zum Hinzufügen mehrfach gesättigter Fettsäuren in Milch
US6541030B2 (en) 2000-09-27 2003-04-01 Verion Inc. Instant water dissolvable encapsulate and process
EP1197207B1 (en) * 2000-10-10 2008-04-23 Wyeth Holdings Corporation Stable compositions for parenteral administration
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
RU2331410C2 (ru) * 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
BRPI0417348A (pt) * 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
KR20060109481A (ko) * 2003-12-04 2006-10-20 화이자 프로덕츠 인코포레이티드 바람직하게는 폴록사머와 글리세라이드를 함유하는다미립자 아지트로마이신 조성물의 제조를 위해 압출기를사용하는 분무응결 방법
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8221809B2 (en) * 2006-06-22 2012-07-17 Martek Biosciences Corporation Encapsulated labile compound compositions and methods of making the same
JP5048773B2 (ja) 2006-08-09 2012-10-17 インターシア セラピューティクス，インコーポレイティド 浸透圧式デリバリーシステム及びピストンアセンブリー
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
NZ604997A (en) * 2008-09-04 2014-07-25 Astrazeneca Pharmaceuticals Lp Sustained release formulations using non-aqueous carriers
JP5494957B2 (ja) 2009-06-11 2014-05-21 株式会社リコー 静電荷像現像用トナー、現像剤、画像形成方法及び画像形成装置
SMT201700583T1 (it) 2009-09-28 2018-01-11 Intarcia Therapeutics Inc Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9364549B2 (en) * 2011-11-30 2016-06-14 Andreas Voigt Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
EP3003266A2 (en) * 2013-05-29 2016-04-13 Therakine Biodelivery GmbH Hydrophilic microparticles, drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
WO2020172629A1 (en) * 2019-02-21 2020-08-27 ChromaDex Inc. Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
US4666839A (en) * 1982-12-01 1987-05-19 Amgen Methods and materials for obtaining microbial expression of polypeptides including bovine prolactin
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4603044A (en) * 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
DE3527356A1 (de) * 1985-07-31 1987-02-05 Degussa Verfahren zur verbesserung der fruchtbarkeit von haustieren
SE462894B (sv) * 1985-10-28 1990-09-17 Biogram Ab Mikrokapslar, foerfarande foer framstaellning daerav samt anvaendning
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles

Also Published As

Publication number Publication date
ATE106240T1 (de) 1994-06-15
AU7397291A (en) 1991-10-03
AR248085A1 (es) 1995-06-30
AU641994B2 (en) 1993-10-07
IE65970B1 (en) 1995-11-29
NO911228L (no) 1991-10-01
HU911054D0 (en) 1991-10-28
CN1063941C (zh) 2001-04-04
YU57091A (sh) 1994-01-20
YU47650B (sh) 1995-12-04
RU2011377C1 (ru) 1994-04-30
BG60850B1 (bg) 1996-05-31
FI101676B1 (fi) 1998-08-14
NO911228D0 (no) 1991-03-26
ES2054380T3 (es) 1994-08-01
US5213810A (en) 1993-05-25
IL97145A0 (en) 1992-05-25
KR910016322A (ko) 1991-11-05
FI101676B (fi) 1998-08-14
DE69102176D1 (de) 1994-07-07
DE69102176T2 (de) 1995-01-05
PL289657A1 (en) 1992-01-13
EP0448930A1 (en) 1991-10-02
HU219584B (hu) 2001-05-28
BG93923A (bg) 1993-12-24
JPH04221319A (ja) 1992-08-11
CN1055293A (zh) 1991-10-16
CZ283053B6 (cs) 1997-12-17
HUT59834A (en) 1992-07-28
FI911531L (fi) 1991-10-01
PL167692B1 (en) 1995-10-31
PT97160B (pt) 1998-07-31
FI911531A0 (fi) 1991-03-28
PT97160A (pt) 1991-11-29
IE911041A1 (en) 1991-10-09
CA2039491A1 (en) 1991-10-01
SK279461B6 (sk) 1998-11-04
RO106191B1 (ro) 1993-03-31
NZ237509A (en) 1993-04-28
NO300717B1 (no) 1997-07-14
IL97145A (en) 1996-06-18
ZA912398B (en) 1992-01-29
KR0159778B1 (ko) 1998-12-01
EP0448930B1 (en) 1994-06-01
MX172602B (es) 1993-01-03
JP2966564B2 (ja) 1999-10-25
CA2039491C (en) 2001-09-04
HK1000004A1 (en) 1997-10-03

Similar Documents

Publication Publication Date Title
DK0448930T3 (da) Stabile præparater til parenteral administration og fremgangsmåde til fremstilling deraf
DK93992D0 (da) Depotpraeparat og fremgangsmaade til fremstilling deraf
NO20000369L (no) Fremstilling av ribozymer og preparater omfattende slike
DK170187D0 (da) Pharmaceutisk fordelagtigt salt af amlodipin og farmaceutiske praeparater indeholdende dette
DK10289D0 (da) Fremgangsmaade og praeparater til forebyggelse af ulcus
DK149988D0 (da) Stabile farmaceutiske praeparater
NO875232D0 (no) Stabile preparater av ricin-toksin-a-kjede og av rta-immunokonjugater og stabilisator-utsorteringsmetoder derav.
DK210690A (da) Metoder og praeparater til inhibering af blodpladeaggregation
DK130389D0 (da) Catecholderivater og farmaceutiske praeparater omfatende samme
DK430189A (da) Fremgangsmaade til fremstilling af et aromatiseringsmiddel og det fremstillede middel
DK287188D0 (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK650089D0 (da) Furanalkylketoner og farmaceutiske praeparater deraf
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK522888D0 (da) Heterocykliske derivater og farmaceutiske praeparater med indhold af saadanne
DK0512547T3 (da) Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf
DK397788A (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
DK269289A (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
DK449188D0 (da) 2'-deoxy-5-fluoruridinderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
NO952261D0 (no) Antacidiumforbindelser og fremgangsmåte for fremstilling derav
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
NO940250D0 (no) Fluorerte kinoloner, fremgangsmaate for fremstilling og farmasoeytiske preparater inneholdende slike
DK180588D0 (da) Anti-tumor-virksomme praeparater og fremgangsmaade til deres fremstilling
DK276888D0 (da) 3-acylaminomethyl-5,6,7,8-tetrahydro-imidazooe,2-a aapyridinderivater, fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne derivater
DK508689A (da) Organofluorider af tin og fremgangsmaade til fremstilling heraf
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet